D.E. Shaw & Co’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-317,517
| Closed | -$705K | – | 4118 |
|
|
2022
Q2 | $705K | Buy |
317,517
+76,617
| +32% | +$170K | ﹤0.01% | 2853 |
|
|
2022
Q1 | $1.49M | Buy |
240,900
+19,549
| +9% | +$121K | ﹤0.01% | 2630 |
|
|
2021
Q4 | $2.79M | Buy |
221,351
+205,341
| +1,283% | +$2.59M | ﹤0.01% | 2165 |
|
|
2021
Q3 | $1.47M | Buy |
16,010
+11,500
| +255% | +$1.05M | ﹤0.01% | 2279 |
|
|
2021
Q2 | $239K | Buy |
+4,510
| New | +$239K | ﹤0.01% | 3193 |
|
|
2020
Q4 | – | Sell |
-12,926
| Closed | -$646K | – | 2862 |
|
|
2020
Q3 | $646K | Sell |
12,926
-15,192
| -54% | -$759K | ﹤0.01% | 2029 |
|
|
2020
Q2 | $1.3M | Buy |
28,118
+14,946
| +113% | +$692K | ﹤0.01% | 1805 |
|
|
2020
Q1 | $601K | Buy |
+13,172
| New | +$601K | ﹤0.01% | 2074 |
|